The grappa-omeract working group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates

Ying Ying Leung, William Tillett, Ana Maria Orbai, Alexis Ogdie, Lihi Eder, Laura C. Coates, Richard Holland, Anna Antony, Niti Goel, Philip J. Mease, Vibeke Strand, Oliver FitzGerald, Maarten De Wit, Christine A. Lindsay, Kristina Callis Duffin, Dafna D. Gladman

Research output: Contribution to journalArticlepeer-review

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group provided updates at the 2019 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. The working group prioritized 4 domains, including musculoskeletal disease activity (enthesitis and dactylitis), fatigue, physical function, and structural damage. In this report, the working group summarizes its progress in standardizing the core outcome set for these 4 domains.

Original languageEnglish (US)
Pages (from-to)46-49
Number of pages4
JournalJournal of Rheumatology
Volume96
DOIs
StatePublished - Jun 1 2020

Keywords

  • Grappa
  • Omeract
  • Outcome measures
  • Psoriasis
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'The grappa-omeract working group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates'. Together they form a unique fingerprint.

Cite this